Research Analysts’ Updated EPS Estimates for January, 4th (AKZOY, ALPN, ARCO, ARRY, ATO, AU, AVHI, AVVIY, BCC, LFC)

Research Analysts’ updated eps estimates for Thursday, January 4th:

Akzo Nobel (OTCMKTS:AKZOY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $33.00 target price on the stock. According to Zacks, “AkzoNobel is a leading global paints and coatings company and a major producer of specialty chemicals. Their portfolio includes brands such as Dulux, Sikkens, International, Interpon and Eka. “

Alpine Immune Sciences (NASDAQ:ALPN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $13.00 target price on the stock. According to Zacks, “Alpine Immune Sciences Inc. operates as a specialty pharmaceutical company. It engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders and other diseases. Alpine Immune Sciences Inc., formerly known as Nivalis Therapeutics, is based in Seattle, Washington. “

Arcos Dorados (NYSE:ARCO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $11.00 target price on the stock. According to Zacks, “Arcos Dorados Holdings Inc. operates as a franchisee of McDonald’s with its operations divided in Brazil; North Latin America division; South Latin America and the Caribbean division. It also runs quick service restaurants in Latin America and the Caribbean. It has operations in territories in Latin America and the Caribbean, including Argentina, Aruba, Brazil, Chile, Colombia, Costa Rica, Curaçao, Ecuador, French Guiana, Guadeloupe, Martinique, Mexico, Panama, Peru, Puerto Rico, Uruguay, the U.S. Virgin Islands of St. Croix and St. Thomas, and Venezuela. Arcos Dorados Holdings Inc. is headquartered in Buenos Aires, Argentina. “

Array BioPharma (NASDAQ:ARRY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company’s proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. “

Atmos Energy (NYSE:ATO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Atmos Energy Corporation, together with its subsidiaries, engages in the distribution, transmission, and storage of natural gas in the United States. It operates in three segments: Regulated Distribution, Regulated Pipeline, and Nonregulated. The Regulated Distribution segment is involved in regulated natural gas distribution and related sales operations. This segment distributes natural gas to approximately 3 million residential, commercial, public authority, and industrial customers. The Regulated Pipeline segment engages in the pipeline and storage operations. This segment transports natural gas for third parties and manages five underground storage reservoirs in Texas; and provides ancillary services in the pipeline industry. The Nonregulated segment provides natural gas management, marketing, transportation, and storage services to municipalities, local gas distribution companies, and industrial customers primarily in the Midwest and Southeast. “

AngloGold Ashanti (NYSE:AU) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “AngloGold Limited is the largest gold producer at 7 million ounces a year, with reserves of 126 m oz. The company has operations in six countries on three continents, some of which are joint ventures, as well as exploration activities in ten countries. AngloGold can be financially characterized by high cash generation, substantial reinvestment in long-term growth and the payment of significant dividends. The company distinguishes itself from its producer peer group through its active involvement in the development of the gold market, particularly in Asia. “

A V Homes (NASDAQ:AVHI) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $21.00 price target on the stock. According to Zacks, “AV Homes, Inc. is engaged in homebuilding, land development and other real estate operations in Florida and Arizona. The company also builds homes in central Florida and Phoenix under its Joseph Carl Homes brand. It owns and operates active adult communities, including Solivita near Orlando and CantaMia near Phoenix. AV Homes, Inc., formerly known as Avatar Holdings Inc., is based in Poinciana, Florida. “

Aviva (OTCMKTS:AVVIY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $15.00 price target on the stock. According to Zacks, “Aviva has established a competitive position in North America. In the US, the world’s largest savings market, Aviva is the leading provider of indexed annuity and indexed life insurance products. Its principal activity is the provision of financial products and services, focused on the following lines of business: long-term insurance and savings business, fund management and general insurance and health. The company’s business is managed on a geographic basis through a regional management structure based on four regions, U.K., Europe, North America and Asia Pacific. The four regions function as five operating segments as, due to the size of the U.K. region, it is split into two operating segments, U.K. Life and U.K. General Insurance, which undertake long term insurance and savings business and general insurance respectively. “

Boise Cascade (NYSE:BCC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Boise Cascade Company operates as a wood products manufacturer and building materials distributor. The Company manufactures engineered wood products, plywood, lumber and particleboard and distributes wood products, such as decking, EWP, lumber, panel, particleboard, and MDF products. It has operations primarily in the United States and Canada. Boise Cascade Company is headquartered in Boise, Idaho. “

China Life Insurance (NYSE:LFC) was downgraded by analysts at Credit Suisse Group AG from a neutral rating to an underperform rating.

Microsoft (NASDAQ:MSFT) had its buy rating reiterated by analysts at Piper Jaffray Companies.

Volkswagen (OTCMKTS:VLKAY) was upgraded by analysts at Deutsche Bank AG from a hold rating to a buy rating.

Receive News & Ratings for Akzo Nobel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akzo Nobel and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply